EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Account-Based Marketing (ABM) Drives Pharma Event Success and Lead Generation
For pharmaceutical companies conferences trade shows scientific congresses and industry networking events continue to be some of the most valuable channels for building relationships Yet many organizations still measure event success using outdated metrics such as booth visitors badge scans promotional giveaways or the total number of leads collected
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro
Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Liposomes-The Most Successful Nano Drug Delivery System: A Short Overview of Manufacturing Processes
Chandan Adhikari
Liposomes are well-known as excellent drug delivery vehicles, with a variety of drugs authorised, including carry generics. Modern liposome production procedures are often sophisticated multi-batch te...
-
2
PROTACs in Leukemia: A Novel Drug Discovery Strategy from Lab Bench to the Pharmaceutical Market
Andre T. S. Vicente
Jorge A. R. Salvador
PROteolysis-TArgeting Chimeras (PROTACs) are a revolutionary targeted protein degradation strategy. To date, several PROTACs that degrade leukemic oncoproteins have successfully overcome many of the l...
-
3
Pharmacovigilance Strategies to Improve Drug Safety and Post-Market Surveillance
Kate Williamson
One of the most significant attributes of safety of a drug is pharmacovigilance as it is an ongoing observation of drugs during the post-market period. The regulatory compliance, high-technology, and...
-
4
How U.S. Drug Pricing and Tariffs Are Reshaping Big Pharma Profits in 2025
No Author
This article discusses the role of U.S. drug pricing reforms in 2025 and new pharmaceutical tariffs in transforming the profitability of Big Pharma. Although the reforms are intended to make the medic...
-
5
Personalized Medicine and Genomics: Charting a New Course in Drug Innovation
Kate Williamson
These are personalized medicine, which can be attributed to the enhancements in genomics as treatment procedures that are formulated according to people’s genetic make-up offers enhanced efficac...
press releasesRead more...
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
Novartis today announced that the European Commission EC has approved Itvisma onasemnogene abeparvovec for the treatment of children two years and older teens and adults living with q spinal
Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial
Imviva Biotech a clinicalstage biotechnology company developing nextgeneration allogeneic CART cell therapies today announced that the US Food and Drug Administration FDA has granted authorization
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
Drug developers have a new optimized option for USbased manufacturing as AGC Biologics enters a strategic partnership with Pyramid Pharma Services The collaboration combines AGC Biologics expertise in drug substance
Zymeworks to Acquire Theravance Biopharma, Inc.
Zymeworks Inc Nasdaq ZYME the Company a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel multifunctional biotherapeutics
Events Read more...
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
LATEST NEWSRead more...
Abbisko Therapeutics and AstraZeneca Partner to Advance NSCLC Combination Therapy Trial
Abbisko Therapeutics has entered into a strategic collaboration with AstraZeneca to jointly advance the clinical development of a combination therapy for nonsmall cell lung cancer NSCLC
Insilico Medicine and Takeda Collaborate to Advance AI-Driven Drug Discovery
Insilico Medicine has entered into a strategic collaboration with Takeda to use its proprietary PharmaAI platform to support the discovery and development of new drug candidates across Takedas therapeutic areas
Abbisko Therapeutics and AstraZeneca Partner on Clinical Trial for NSCLC Combination Therapy
Abbisko Therapeutics has entered into a strategic collaboration with AstraZeneca to jointly advance the clinical development of a new immunooncology and targeted therapy combination for the treatment of nonsmall cell lung cancer NSCLC
Monopar Therapeutics Receives US FDA Rare Pediatric Disease Designation for ALXN1840
Monopar Therapeutics has received Rare Pediatric Disease RPD designation from the US Food and Drug Administration FDA for ALXN tiomolibdate choline its latestage investigational treatment for Wilson disease
Roche launches AXELIOS 1 next-generation sequencing platform
Roche has launched AXELIOS a nextgeneration sequencing platform based on its proprietary sequencing by expansion SBX technology The platform combines high accuracy speed flexibility scalability and cost efficiency
Innovent Biologics and Lilly sign commercialisation agreement for Verzenios in mainland China
Innovent Biologics and Eli Lilly and Company have entered into a distribution and promotion agreement for Verzenios abemaciclib in mainland China
